Journal Mobile Options
Table of Contents
Vol. 140, No. 1, 2013
Issue release date: May 2013

Duplication of Isodicentric Chromosome 13, idic(13)(p11.2), Leading to Pentasomy 13q in Acute Myeloid Leukemia without Maturation

Kjeldsen E. · Kallenbach M.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Isodicentric chromosome 13, idic(13)(p11.2), is a very rare chromosomal aberration in acute myeloid leukemia (AML). We describe here a novel case of AML without maturation, where the leukemic cells harbored double idic(13)(p11.2) and a normal chromosome 13 resulting in pentasomy 13q. Analyses were done on aspirated bone marrow cells from diagnosis. We utilized G-banding analysis, 24-color karyotyping and additional FISH analyses with various locus-specific probes to characterize the chromosomal complement. Oligonucleotide-based 180K aCGH analysis was done to search for submicroscopic imbalances. The karyotype was 47,XY,idic(13)(p11.2)x2[23]/46,XY[2]. Pantelomeric FISH analysis indicated critically short telomeres. Oligo-based aCGH analysis confirmed high copy gain of chromosome 13q and did not disclose other genomic imbalances. Reviewing the literature, this may be the second case of pentasomy 13q, since idic(13)(p11.2), when analyzed by conventional cytogenetics, is indistinguishable from i(13)(q10). Both cases were associated with immature AML and a poor outcome. We propose that idic(13)(p11.2) is a new recurrent abnormality in AML without maturation and suggest that pentasomy 13q is an early event in pathogenesis of AML through amplification of genes located on 13q.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Al-Wahiby S, Slijepcevic P: Chromosomal aberrations involving telomeres in BRCA1 deficient human and mouse cell lines. Cytogenet Genome Res 109:491-496 (2005).
  2. Aubert G, Lansdorp PM: Telomeres and aging. Physiol Rev 88:557-579 (2008).
  3. Bae NS, Baumann P: A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol Cell 26:323-334 (2007).
  4. Bailey SM, Cornforth MN, Ullrich RL, Goodwin EH: Dysfunctional mammalian telomeres join with DNA double-strand breaks. DNA Repair (Amst) 3:349-357 (2004).
  5. Blackburn EH: Switching and signaling at the telomere. Cell 106:661-673 (2001).
  6. Capraro V, Zane L, Poncet D, Perol D, Galia P, et al: Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. Exp Hematol 39:195-202 (2011).
  7. Chan SW, Blackburn EH: New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene 21:553-563 (2002).
  8. Cuneo A, Ferrant A, Michaux JL, Boogaerts M, Demuynck H, et al: Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: Correlation with clinicobiologic findings. Blood 85:3688-3694 (1995).

    External Resources

  9. de la Chapelle A: How do human isochromosomes arise? Cancer Genet Cytogenet 5:173-179 (1982).
  10. Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, et al: The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98:1312-1320 (2001).
  11. Halazonetis TD, Gorgoulis VG, Bartek J: An oncogene-induced DNA damage model for cancer development. Science 319:1352-1355 (2008).
  12. Hartmann U, Brümmendorf TH, Balabanov S, Thiede C, Illme T, Schaich M: Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities. Haematologica 90:307-316 (2005).

    External Resources

  13. Hecht F, Morgan R, Hecht BK: Robertsonian chromosome recombinants are rare in cancer. Cancer Genet Cytogenet 35:79-81 (1988).
  14. Hemann MT, Strong MA, Hao LY, Greider CW: The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107:67-77 (2001).
  15. Hsu LYF: Prenatal diagnosis of chromosomal abnormalities through amnicentesis, in Milunsky A (ed): Genetic Disorders of the Fetus: Diagnosis, Prevention, and Treatment, pp 179-248 (The John Hopskins University Press, Baltimore 1998).
  16. Huang J, Okuka M, McLean M, Keefe DL, Liu L: Telomere susceptibility to cigarette smoke-induced oxidative damage and chromosomal instability of mouse embryos in vitro. Free Radic Biol Med 48:1663-1676 (2010).
  17. Janssen A, van der Burg M, Szuhai K, Kops GJ, Medema RH: Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333:1895-1898 (2011).
  18. Jørgensen AL, Bostock CJ, Bak AL: Homologous subfamilies of human alphoid repetitive DNA on different nucleolus organizing chromosomes. Proc Natl Acad Sci USA 84:1075-1079 (1987).
  19. Kjeldsen E, Roug AS: A novel unbalanced de novo translocation der(5)t(4;5)(q26;q21.1) in adult T-cell precursor lymphoblastic leukemia. Mol Cytogenet 5:21 (2012).
  20. Klaus M, Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C: Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization. Cancer Genet Cytogenet 155:47-56 (2004).
  21. Klein G: Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men. Cell 32:311-315 (1983).
  22. Lange K, Holm L, Vang Nielsen K, Hahn A, Hofmann W, et al: Telomere shortening and chromosomal instability in myelodysplastic syndromes. Genes Chromosomes Cancer 49:260-269 (2010).
  23. Lee J, Sandford AJ, Connett JE, Yan J, Mui T, et al: The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD). PloS One 7:e35567 (2012).
  24. Loglisci G, Breccia M, Nanni M, Mancini M, De Cuia R, et al: Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib. Leuk Lymphoma 52:1372-1375 (2011).
  25. Martínez P, Blasco MA: Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11:161-176 (2011).
  26. Maser RS, DePinho RA: Telomeres and the DNA damage response: why the fox is guarding the henhouse. DNA Repair (Amst) 3:979-988 (2004).
  27. Ohyashiki K, Iwama H, Yahata N, Tauchi T, Kawakubo K, et al: Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation. Leuk Lymphoma 42:291-299 (2001).
  28. Ramond S, Cacheux V, Ciaudo M, Cadiou M, Perrot JY, et al: Pentasomy 13q in a case of acute myelogenous leukemia (Mo). Cancer Genet Cytogenet 107:73-75 (1998).
  29. Roche-Lestienne C, Richebourg S, Laï JL, Andrieux J, Soenen-Cornu V, Geffroy S: Isolated tetrasomy 13: a fifth case report of a rare chromosome abnormality associated with poorly differentiated acute myeloid leukemia. Cancer Genet Cytogenet 168:181-182 (2006).
  30. Sarthy J, Bae NS, Scrafford J, Baumann P: Human RAP1 inhibits non-homologous end joining at telomeres. EMBO J 28:3390-3399 (2009).
  31. Sashida G, Ohyashiki JH, Nakajima A, Sumi M, Kawakubo K, et al: Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases. Clin Cancer Res 9:1489-1496 (2003).

    External Resources

  32. Shimoyama M, Yamamoto K, Nishikawa S, Minagawa K, Katayama Y, Matsui T: Duplication of isodicentric chromosome 21, idic(21)(p11.2), leading to pentasomy 21q in acute myeloid leukemia with multilineage dysplasia. Cancer Genet Cytogenet 194:38-43 (2009).
  33. Sieglová Z, Zilovcová S, Cermák J, Ríhová H, Brezinová D, et al: Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis? Leuk Res 28:1013-1021 (2004).
  34. Silva FP, Morolli B, Storlazzi CT, Zagaria A, Impera L, et al: ETV6 mutations and loss in AML-M0. Leukemia 22:1639-1643 (2008).
  35. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al: WHO Classification of Tumours of Haematopoitic and Lymphoid Tissues, ed 4 (International Agency for Research on Cancer, Lyon 2008).
  36. Testa JR, Misawa S, Oguma N, Van Sloten K, Wiernik PH: Chromosomal alterations in acute leukemia patients studied with improved culture methods. Cancer Res 45:430-434 (1985).

    External Resources

  37. Walter TA, Müllerleile U, Galinke I, Weh HJ, Hossfeld DK: A case of adult ALL with +i(13q) as the sole anomaly. Cancer Genet Cytogenet 60:193-194 (1992).
  38. Welborn J: Acquired Robertsonian translocations are not rare events in acute leukemia and lymphoma. Cancer Genet Cytogenet 151:14-35 (2004).
  39. Wolff DJ, Schwartz S: Characterization of Robertsonian translocations by using fluorescence in situ hybridization. Am J Hum Genet 50:174-181 (1992).

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50